Roche, Applera win enhanced damages from MJ Research:
This article was originally published in Clinica
In a patent dispute over polymerase chain reaction (PCR) and thermal cycler technology dating back to 1998, Roche Diagnostics and Applera company Applied Biosystems have been granted enhanced damages from MJ Research, a company that is now owned by Bio-Rad. The district court in Connecticut doubled the damages previously awarded by a jury to the two companies to $35.4m plus attorney fees, saying that MJ Research displayed an exceptional degree of dismissiveness of patent rights and disrespect for the law. It ordered the enhanced damages "to punish this conduct and deter similar behaviour". Antitrust counterclaims by MJ Research were dismissed in December 2004.
You may also be interested in...
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.
Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.
Mylan, in partnership with Indian firm Lupin, will be looking to rival Biogen and Sandoz by introducing an etanercept biosimilar in European markets following a positive opinion by the EMA’s CHMP on Mylan's application.